TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro

SIMPLE SUMMARY: TERT promoter mutations are the most frequent mutations in melanoma, co-occur regularly with BRAF alterations and are associated with a poorer prognosis. Conflicting results have been published on the role of TERT promoter mutations in resistance to targeted therapy in melanoma. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Delyon, Julie, Vallet, Anaïs, Bernard-Cacciarella, Mélanie, Kuzniak, Isabelle, Reger de Moura, Coralie, Louveau, Baptiste, Jouenne, Fanélie, Mourah, Samia, Lebbé, Céleste, Dumaz, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251862/
https://www.ncbi.nlm.nih.gov/pubmed/37296851
http://dx.doi.org/10.3390/cancers15112888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251862/
https://www.ncbi.nlm.nih.gov/pubmed/37296851
http://dx.doi.org/10.3390/cancers15112888

Ejemplares similares